LAND for the new Papworth Hospital has been bought on the Cambridge Biomedical Campus in preparation for work to start in the New Year.
This news comes just weeks after it was confirmed that Papworth Hospital has gained planning permission for the bespoke 310-bed cardiothoracic hospital to be built on the world-class biomedical hub in Cambridge.
Work will begin on the site, which is over 7-acres in size and centrally located on the campus, once the project has reached financial close in early 2015.
Chief Executive, Stephen Bridge, said: “We are delighted to be announcing another step forward in the New Papworth Hospital project this month. The purchase of the land where the New Papworth Hospital is set to be built on the Cambridge Biomedical Campus means that once financial close has been reached Skanska can immediately begin working on site.”
He added: “I am pleased that we have reached such a stage within this project after many years of planning and discussions surrounding the New Papworth Hospital. Moving to the campus will allow us to continue to lead in cardiothoracic care and to offer our patients the very best standard of care.
”The New Papworth Hospital is set to open in Cambridge in early 2018 and will form part of the UK’s largest biomedical campus. The hospital will be located alongside some of the world’s leading healthcare companies, hospitals and education & research establishments.
Christine de Ferrars Green, a partner at law firm Mills & Reeve which advised
on the land purchase, said: “We were delighted to have worked with the
Trust’s project team to achieve this milestone and to assist the Trust as it takes another significant step on the way to bringing the new hospital to Cambridge.
A member of Cambridge University Health Partners “Completion of the land acquisition is the culmination of many years’ work, to convert the option to purchase into ownership, which has seen us advising on the developer’s obligations for the provision of essential roads and servicing infrastructure across the wider Cambridge Biomedical Campus and surmounting a number of legal hurdles along the way.”